Xeris Biopharma Holdings Inc
XERS
Market Cap$760.74M
Close$
$2.89
39.1% downside
Current Fair Value
39.1% downsideOvervalued by 39.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $760.74 Million |
|---|---|
| Enterprise Value | $971.05 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.37 |
| Beta | 0.91 |
| Outstanding Shares | 152,445,935 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -16.06 |
|---|---|
| PEG | 31.24 |
| Price to Sales | 4.75 |
| Price to Book Ratio | -4.75 |
| Enterprise Value to Revenue | 4.39 |
| Enterprise Value to EBIT | -39.28 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | -7.65 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Xeris Pharmaceuticals Inc
CEO: paul Edick